Blue Cap AG (B7E) Fair Value & Analysis
Financial Services · DE · Market cap €75.1M
Fair value as of: Jul 17, 2026
From 13 valuation models · updated 24 days ago
Fair value updated Jul 17, 2026, revised from €34.58 to €32.00 (−7.5%) since Jun 26, 2026. Share price −5.7% over the past month.
A solid business, screening 95% undervalued on our models.
What matters now
- The price is below even our cautious bear case (€24.00). The market is more pessimistic than our downside scenario.
- Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range €13.21 – €28.89 · fair‑value band €24.00 – €40.00 · the €16.40 price screens below the €32.00 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
Blue Cap AG (B7E) currently trades at €16.40, while our model-based Fair Value estimate is €32.00, implying the stock looks roughly 95.1% undervalued today. The Quality Score stands at 60/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Blue Cap AG generated revenue of €202M at a net margin of 10.1%. Revenue declined 4.3% year over year. It earns a return on equity of 9.1%. The balance sheet holds a net cash position of €50.5M. Fundamentals as of Jul 17, 2026
Our scenario range runs from €24.00 (bear case) to €40.00 (bull case); at €16.40, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at 95%, B7E screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Earnings-Based (€183.27) versus Dividend Discount (€12.17). Highest evidence: Growth DCF (80).
Notify me when B7E reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 59 · Market factors (momentum, volatility) 44
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Blue Cap AG is a private equity firm based in Munich, Germany, specializing in investments in middle market, late-stage, mature, turnaround, recapitalization, buyout, special situations, restructuring, corporate carve-outs, and growth capital.
Full company description
Blue Cap AG is a private equity firm based in Munich, Germany, specializing in investments in middle market, late-stage, mature, turnaround, recapitalization, buyout, special situations, restructuring, corporate carve-outs, and growth capital. It focuses on SMEs, particularly B2B companies in industrial goods and services across sectors such as adhesives & coatings, plastics, business services, and medical. The firm targets investments in Germany, Austria, and Switzerland, typically ranging from $5.65 million to $28.3 million in equity, with target sales between "20 million ($23.46 million) and "200 million ($234.65 million), and EBITDA up to $10 million. Blue Cap prefers majority stakes and aims for exits within three to seven years, investing from its balance sheet capital. Founded in 2006, the firm operates with a long-term, value-driven approach.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Blue Cap AG reported revenue of €137M in FY2025 versus €267M in FY2021, a compound −15.4%/yr. Reported net income was €23.5M in FY2025, compounding +46.1%/yr from FY2021.
of which total revenue +7.6 pp · buybacks/dilution −1.8 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch B7E: get an alert when its fair value changes →
Peer Group
Asset Management · 971 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Asset Management median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $0.0420 | $0.0800 | +90% |
| BlackRock, Inc BLK | $1,136 | $465.75 | -59% |
| Blackstone Inc BX | $124.56 | $16.35 | -87% |
| Investor AB INVEB | kr 423.70 | kr 847.40 | +100% |
| Brookfield Corporation BN | C$62.45 | C$10.12 | -84% |
| KKR & Co KKR | $100.94 | $44.88 | -56% |
| AB Industrivärden INDUA | kr 532.50 | kr 1,065 | +100% |
| Jio Financial Services Limited JIOFIN | ₹242.98 | ₹40.19 | -83% |
| Hedef Holding HEDEF | 267.25 TRY | 320.98 TRY | +20% |
| Bajaj Holdings BAJAJHLDNG | ₹10,398 | ₹9,202 | -12% |
Compare Blue Cap AG with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Blue Cap AG (B7E) overvalued or undervalued?
What is the fair value of B7E?
What is the quality score of B7E?
What is the revenue of Blue Cap AG (B7E)?
What is the net profit margin of B7E?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Blue Cap AG and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.